NKGen Biotech Files 8-K for Material Agreement
| Field | Detail |
|---|---|
| Company | Nkgen Biotech, Inc. |
| Form Type | 8-K |
| Filed Date | Jul 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
Related Tickers: NKGN
TL;DR
NKGen Biotech signed a big deal on 7/14/25. Details to follow.
AI Summary
On July 14, 2025, NKGen Biotech, Inc. entered into a material definitive agreement. The company, formerly known as Graf Acquisition Corp. IV, is incorporated in Delaware and operates in the biological products sector. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates a significant development for NKGen Biotech, potentially involving new partnerships, acquisitions, or financing that could impact its future operations and stock value.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce significant opportunities or risks depending on their terms, which are not fully detailed in this initial 8-K filing.
Key Numbers
- 001-40427 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- NKGen Biotech, Inc. (company) — Registrant
- Graf Acquisition Corp. IV (company) — Former Company Name
- July 14, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by NKGen Biotech, Inc. on July 14, 2025?
The filing states that NKGen Biotech, Inc. entered into a material definitive agreement on July 14, 2025, but the specific details of this agreement are not provided in this initial 8-K filing.
What was NKGen Biotech, Inc.'s former company name?
NKGen Biotech, Inc.'s former company name was Graf Acquisition Corp. IV.
In which state is NKGen Biotech, Inc. incorporated?
NKGen Biotech, Inc. is incorporated in Delaware.
What is the SIC code for NKGen Biotech, Inc.?
The Standard Industrial Classification (SIC) code for NKGen Biotech, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the SEC file number for NKGen Biotech, Inc.?
The SEC file number for NKGen Biotech, Inc. is 001-40427.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 17, 2025 regarding NKGen Biotech, Inc..